Tower Trust & Investment Company’s Pfizer PFE Stock Holding History

Tower Trust & Investment Company’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$456K	Sell	18,965 -2,740	-13%	-$71.7K	0.28%	74
2026 Q1	$609K	Buy	21,705 +302	+1%	+$8.04K	0.4%	64
2025 Q4	$533K	Buy	21,403 +929	+5%	+$23.4K	0.34%	73
2025 Q3	$521K	Buy	20,474 +56	+0.3%	+$1.38K	0.35%	69
2025 Q2	$495K	Buy	20,418 +1,758	+9%	+$41K	0.35%	70
2025 Q1	$455K	Buy	+18,660	New	+$488K	0.37%	71

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Tower Trust & Investment Company's PFE Position: Q2 2026 in Review

Tower Trust & Investment Company reduced its Pfizer (PFE) stake by 13% in Q2 2026, selling an estimated $71.7K and leaving 18,965 shares worth $456K. The position accounts for 0.28% of the portfolio, ranked #74.

Tower Trust & Investment Company first reported a position in PFE in Q1 2025 and has held it in 6 quarters since. The position peaked at $609K in Q1 2026. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Tower Trust & Investment Company held 18,965 shares of Pfizer worth $456K as of Q2 2026.
Tower Trust & Investment Company sold 2,740 Pfizer shares in Q2 2026, an estimated $71.7K.
Pfizer made up 0.28% of Tower Trust & Investment Company's portfolio in Q2 2026, its #74 holding.
Tower Trust & Investment Company first reported a position in Pfizer in Q1 2025 and has held it in 6 quarters since.
Tower Trust & Investment Company's Pfizer position peaked at $609K in Q1 2026.
1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Tower Trust & Investment Company's 13F filing for Q2 2026, filed 9 Jul 2026.